We are live on
!
Find out more
Nektar Therapeutics
NKTR
NKTR
109 hedge funds and large institutions have $198M invested in Nektar Therapeutics in 2025 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 33 increasing their positions, 34 reducing their positions, and 76 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
29% less funds holding
Funds holding: 154 → 109 (-45)
58% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 76
Holders
109
Holding in Top 10
1
Calls
$32.1M
Puts
$35.6M
Top Buyers
| 1 | +$5.57M | |
| 2 | +$3.7M | |
| 3 | +$2.14M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.08M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.07M |
Top Sellers
| 1 | -$7.1M | |
| 2 | -$4.52M | |
| 3 | -$3.14M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.88M |
| 5 |
EAM
Exome Asset Management
New York
|
-$1.67M |